Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.